We are live on
!
Find out more
NVRO
NEVRO CORP.
NVRO
NVRO
Delisted
NVRO was delisted on the 2nd of April, 2025.
210 hedge funds and large institutions have $4.98B invested in NEVRO CORP. in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 79 increasing their positions, 77 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
31% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 26
12% more capital invested
Capital invested by funds: $4.45B → $4.98B (+$530M)
4% more funds holding
Funds holding: 202 → 210 (+8)
3% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 77
0% more call options, than puts
Call options by funds: $34.4M | Put options by funds: $34.2M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
210
Holders Change
+8
Holders Change %
+3.96%
% of All Funds
4.24%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
34
Increased
79
Reduced
77
Closed
26
Calls
$34.4M
Puts
$34.2M
Net Calls
+$160K
Net Calls Change
+$11.1M
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$28.6M |
| 2 |
Jennison Associates
New York
|
+$28M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.7M |
| 4 |
Millennium Management
New York
|
+$18.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$16.9M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$68.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$44.3M |
| 3 |
HM
HealthCor Management
New York
|
-$43.2M |
| 4 |
Renaissance Technologies
New York
|
-$21.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$18.1M |
